Mineralys Therapeutics, Inc.·4

Feb 20, 7:46 PM ET

Levy Adam Scott 4

4 · Mineralys Therapeutics, Inc. · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Mineralys (MLYS) CFO Adam Levy Receives RSUs and Option Award

What Happened

  • Adam Scott Levy, CFO and Secretary of Mineralys Therapeutics (MLYS), received equity awards on February 19, 2026. The filing shows a grant of 39,900 Restricted Stock Units (RSUs) and a derivative award covering 53,300 share-equivalents, both reported at $0.00 acquisition price. Combined, these awards represent 93,200 share-equivalents granted as compensation (no cash paid).

Key Details

  • Transaction date: 2026-02-19; Form 4 filed 2026-02-20 (timely).
  • Reported consideration: $0.00 (awarded as compensation).
  • RSU grant: 39,900 RSUs (footnote F1) — each RSU converts to one share on vesting; vests in annual installments over four years (1/4 each year).
  • Derivative grant: 53,300 share-equivalents (footnote F2 indicates an option-style award) — vests monthly over four years (1/48 each month).
  • Shares owned after transaction: not specified in the provided Form 4 data.
  • No sale, purchase, or cash exercise reported; these are compensation grants, not open-market trades.

Context

  • RSUs become actual shares only as they vest; the derivative award appears to be an option-like instrument that vests monthly and does not represent immediately tradable shares until vested/exercised.
  • Grants like these are common for executive compensation and do not by themselves indicate insider buying or selling intent.

Insider Transaction Report

Form 4
Period: 2026-02-19
Levy Adam Scott
CFO and Secretary
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-19+39,90048,538 total
  • Award

    Stock Option

    [F2]
    2026-02-19+53,30053,300 total
    Exercise: $28.06Exp: 2036-02-19Common Stock (53,300 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant.
  • [F2]The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant
Signature
/s/ Adam Levy|2026-02-20

Documents

1 file
  • 4
    wk-form4_1771634807.xmlPrimary

    FORM 4